HRP940890B1 - Novel(r)-5-carbamoyl-8-fluoro-3-n,n-disubstituted-amino-3,4-dihydro-2h-1-benozpyranes - Google Patents
Novel(r)-5-carbamoyl-8-fluoro-3-n,n-disubstituted-amino-3,4-dihydro-2h-1-benozpyranesInfo
- Publication number
- HRP940890B1 HRP940890B1 HR940890A HRP940890A HRP940890B1 HR P940890 B1 HRP940890 B1 HR P940890B1 HR 940890 A HR940890 A HR 940890A HR P940890 A HRP940890 A HR P940890A HR P940890 B1 HRP940890 B1 HR P940890B1
- Authority
- HR
- Croatia
- Prior art keywords
- amino
- fluoro
- benozpyranes
- disubstituted
- carbamoyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D335/00—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom
- C07D335/04—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D335/06—Benzothiopyrans; Hydrogenated benzothiopyrans
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
- C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
- C07D407/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Epidemiology (AREA)
- Cardiology (AREA)
- Hospice & Palliative Care (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Indole Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/144,671 US5420151A (en) | 1989-12-22 | 1993-10-28 | Chroman derivatives |
Publications (2)
Publication Number | Publication Date |
---|---|
HRP940890A2 HRP940890A2 (en) | 1996-12-31 |
HRP940890B1 true HRP940890B1 (en) | 2001-12-31 |
Family
ID=22509617
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HR940890A HRP940890B1 (en) | 1993-10-28 | 1994-10-28 | Novel(r)-5-carbamoyl-8-fluoro-3-n,n-disubstituted-amino-3,4-dihydro-2h-1-benozpyranes |
Country Status (36)
Country | Link |
---|---|
US (9) | US5420151A (fi) |
EP (1) | EP0725779B1 (fi) |
JP (1) | JP3089276B2 (fi) |
CN (1) | CN1062269C (fi) |
AT (1) | ATE203019T1 (fi) |
AU (1) | AU687115B2 (fi) |
BR (1) | BR9407910A (fi) |
CA (1) | CA2173257C (fi) |
CZ (1) | CZ284371B6 (fi) |
DE (1) | DE69427704T2 (fi) |
DK (1) | DK0725779T3 (fi) |
EE (1) | EE03253B1 (fi) |
ES (1) | ES2160640T3 (fi) |
FI (1) | FI961809A (fi) |
GR (1) | GR3036816T3 (fi) |
HK (1) | HK1002898A1 (fi) |
HR (1) | HRP940890B1 (fi) |
HU (1) | HUT75060A (fi) |
IL (1) | IL111365A (fi) |
IS (1) | IS1904B (fi) |
LV (1) | LV12811B (fi) |
MY (1) | MY111616A (fi) |
NO (1) | NO314146B1 (fi) |
NZ (1) | NZ275176A (fi) |
PL (1) | PL178840B1 (fi) |
PT (1) | PT725779E (fi) |
RU (1) | RU2142951C1 (fi) |
SA (1) | SA94150317B1 (fi) |
SG (1) | SG52320A1 (fi) |
SI (1) | SI0725779T1 (fi) |
SK (1) | SK280527B6 (fi) |
TW (1) | TW399049B (fi) |
UA (1) | UA44717C2 (fi) |
WO (1) | WO1995011891A1 (fi) |
YU (1) | YU49048B (fi) |
ZA (1) | ZA948353B (fi) |
Families Citing this family (36)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5616610A (en) * | 1989-12-22 | 1997-04-01 | Astra Aktiebolag | (R)-5-carbamoyl-8-fluoro-3-N,N-disubstituted-amino-3,4-dihydro-2H-1-benzopyrans |
ES2102456T3 (es) * | 1991-02-08 | 1997-08-01 | Lilly Co Eli | 3-amino-1,2,3,4-tetrahidronaftalenos sustituidos en el anillo. |
EP0677519A4 (en) * | 1993-11-10 | 1996-04-03 | Japan Tobacco Inc | CHROMAN DERIVATIVE AND THERAPEUTIC USE THEREOF. |
SE9501567D0 (sv) * | 1995-04-27 | 1995-04-27 | Astra Ab | A new combination |
US5990114A (en) * | 1996-02-28 | 1999-11-23 | Recordati, S.A., Chemical And Pharmaceutical Company | Use of 5-HT1A receptor antagonists for the treatment of urinary incontinence |
SE9701438D0 (sv) * | 1997-04-17 | 1997-04-17 | Astra Ab | A new process |
SE510305C2 (sv) * | 1997-05-30 | 1999-05-10 | Astra Ab | Nytt salt |
US7799337B2 (en) | 1997-07-21 | 2010-09-21 | Levin Bruce H | Method for directed intranasal administration of a composition |
SE9703377D0 (sv) * | 1997-09-18 | 1997-09-18 | Astra Ab | New compounds |
SE9703378D0 (sv) | 1997-09-18 | 1997-09-18 | Astra Ab | New compounds |
US5962488A (en) * | 1998-04-08 | 1999-10-05 | Roberts Laboratories, Inc. | Stable pharmaceutical formulations for treating internal bowel syndrome containing isoxazole derivatives |
US6310066B1 (en) | 1998-04-29 | 2001-10-30 | American Home Products Corp. | Antipsychotic indolyl derivatives |
US6204274B1 (en) | 1998-04-29 | 2001-03-20 | American Home Products Corporation | Indolyl derivatives as serotonergic agents |
US6066637A (en) * | 1998-06-19 | 2000-05-23 | American Home Products Corporation | Indolyl derivatives as serotonergic agents |
AU2002217742B2 (en) | 2001-01-16 | 2008-02-21 | Astrazeneca Ab | Therapeutic heterocyclic compounds |
US7032572B2 (en) * | 2002-06-04 | 2006-04-25 | Ford Global Technologies, Llc | Method for controlling an engine to obtain rapid catalyst heating |
SE0301795D0 (sv) * | 2003-06-19 | 2003-06-19 | Astrazeneca Ab | New use I |
SE0301796D0 (sv) * | 2003-06-19 | 2003-06-19 | Astrazeneca Ab | New use II |
US20050032873A1 (en) * | 2003-07-30 | 2005-02-10 | Wyeth | 3-Amino chroman and 2-amino tetralin derivatives |
US20060205807A1 (en) * | 2005-02-16 | 2006-09-14 | Wyeth | Amino-chroman compounds and methods for preparing same |
WO2007095586A2 (en) * | 2006-02-14 | 2007-08-23 | The Trustees Of Columbia University In The City Of New York | Neuronal pain pathway modulators |
CN101627023A (zh) * | 2006-12-12 | 2010-01-13 | 拜尔坡特拉有限公司 | 用于不对称氢化的催化方法 |
US8473062B2 (en) * | 2008-05-01 | 2013-06-25 | Autonomic Technologies, Inc. | Method and device for the treatment of headache |
US8412336B2 (en) * | 2008-12-29 | 2013-04-02 | Autonomic Technologies, Inc. | Integrated delivery and visualization tool for a neuromodulation system |
US8494641B2 (en) * | 2009-04-22 | 2013-07-23 | Autonomic Technologies, Inc. | Implantable neurostimulator with integral hermetic electronic enclosure, circuit substrate, monolithic feed-through, lead assembly and anchoring mechanism |
US9320908B2 (en) * | 2009-01-15 | 2016-04-26 | Autonomic Technologies, Inc. | Approval per use implanted neurostimulator |
US20100185249A1 (en) * | 2009-01-22 | 2010-07-22 | Wingeier Brett M | Method and Devices for Adrenal Stimulation |
WO2018023072A2 (en) | 2016-07-29 | 2018-02-01 | Sunovion Pharmaceuticals, Inc. | Compounds and compositions and uses thereof |
EP3490607A4 (en) * | 2016-07-29 | 2020-04-08 | Sunovion Pharmaceuticals Inc. | COMPOUNDS AND COMPOSITIONS, AND USES THEREOF |
CA2972203C (en) | 2017-06-29 | 2018-07-17 | Exxonmobil Upstream Research Company | Chasing solvent for enhanced recovery processes |
CA2974712C (en) | 2017-07-27 | 2018-09-25 | Imperial Oil Resources Limited | Enhanced methods for recovering viscous hydrocarbons from a subterranean formation as a follow-up to thermal recovery processes |
JP7191085B2 (ja) | 2017-08-02 | 2022-12-16 | サノビオン ファーマシューティカルズ インク | イソクロマン化合物およびその使用 |
CA2978157C (en) | 2017-08-31 | 2018-10-16 | Exxonmobil Upstream Research Company | Thermal recovery methods for recovering viscous hydrocarbons from a subterranean formation |
CA2983541C (en) | 2017-10-24 | 2019-01-22 | Exxonmobil Upstream Research Company | Systems and methods for dynamic liquid level monitoring and control |
MX2021010880A (es) | 2019-03-14 | 2022-01-18 | Sunovion Pharmaceuticals Inc | Sales de un compuesto de isocromanilo y formas cristalinas, procesos de preparacion, usos terapeuticos y composiciones farmaceuticas de las mismas. |
US12007369B2 (en) * | 2021-04-01 | 2024-06-11 | Saudi Arabian Oil Company | Residual corrosion inhibitor monitoring |
Family Cites Families (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BE795874A (fr) * | 1972-02-25 | 1973-08-23 | Glaxo Lab Ltd | Procede de preparation d'esters optiquement actifs d'alpha-amino-acides |
JPS60152425A (ja) * | 1984-01-20 | 1985-08-10 | Oyo Seikagaku Kenkyusho:Kk | ラセミ体の新規な光学分割法 |
US4683223A (en) * | 1985-09-09 | 1987-07-28 | Warner-Lambert Company | N6 -Benzopyrano-and benzothiopyrano adenosines and methods of use |
DE3679378D1 (de) * | 1985-09-03 | 1991-06-27 | Ciba Geigy Ag | 3-amino-dihydro-(1)-benzopyrane und benzothiopyrane. |
FR2593504B1 (fr) * | 1986-01-30 | 1988-12-09 | Ile De France | Nouveaux derives de dihydrobenzofuranne - et de chromane - carboxamides, leurs procedes de preparation et leur utilisation comme neuroleptiques |
US4801605A (en) * | 1986-08-29 | 1989-01-31 | Ciba-Geigy Corporation | 3-amino-dihydro-[1]-benzopyrans and benzothiopyrans |
SE8605504D0 (sv) * | 1986-12-19 | 1986-12-19 | Astra Laekemedel Ab | Novel chroman derivatives |
DE3719924A1 (de) * | 1986-12-22 | 1988-06-30 | Bayer Ag | 8-substituierte 2-aminotetraline |
US4971982A (en) * | 1987-07-06 | 1990-11-20 | Hoffmann-La Roche Inc. | Benzopyran derivatives |
US5214156A (en) * | 1988-03-25 | 1993-05-25 | The Upjohn Company | Therapeutically useful tetralin derivatives |
US5021432A (en) * | 1988-04-26 | 1991-06-04 | Yoshitomi Pharmaceutical Industries, Ltd. | Benzopyran compound and its pharmaceutical use |
CA1335591C (en) * | 1988-05-23 | 1995-05-16 | James Arthur Nixon | Ring-substituted 2-amino-1,2,3,4-tetrahydronaphthalenes |
US5026707A (en) * | 1988-05-23 | 1991-06-25 | Eli Lilly And Company | Ring-substituted 2-amino-1,2,3,4-tetrahydronaphthalenes |
DE3901814A1 (de) * | 1988-07-28 | 1990-02-01 | Bayer Ag | Substituierte aminomethylzetraline sowie ihre heterocyclischen analoga |
FR2639349B1 (fr) * | 1988-11-23 | 1991-02-22 | Sanofi Sa | Nouveaux derives du chromane actifs sur le systeme nerveux central, leur procede de preparation et les compositions pharmaceutiques en contenant |
US5225596A (en) * | 1989-01-09 | 1993-07-06 | The Upjohn Company | Halo substituted aminotetralins |
IL114715A (en) * | 1989-02-27 | 1997-01-10 | Lilly Co Eli | Intermediate compounds for ring-substituted 2-amino-1, 2, 3, 4-tetrahydronaphthalenes and 3-aminochromanes |
US5306830A (en) * | 1989-04-27 | 1994-04-26 | The Upjohn Company | Substituted 3-amino chromans |
ATE172712T1 (de) * | 1989-05-31 | 1998-11-15 | Upjohn Co | Zns-wirksame 8-heterocyclyl-2-aminotetralin derivate |
DE3942418A1 (de) * | 1989-12-21 | 1991-06-27 | Guenther Strecker | Gestellstab |
SE8904361D0 (sv) * | 1989-12-22 | 1989-12-22 | Astra Ab | New chroman and thiochroman derivatives |
ES2100211T3 (es) * | 1990-08-15 | 1997-06-16 | Lilly Co Eli | 2-amino-1,2,3,4-tetrahidronaftalenos, 3-aminocromanos y 3-aminotiocromanos sustituidos en el anillo. |
HRP920935A2 (en) * | 1991-10-08 | 1995-08-31 | Astra Ab | New therapeutically active compound |
-
1993
- 1993-10-28 US US08/144,671 patent/US5420151A/en not_active Expired - Fee Related
-
1994
- 1994-09-09 US US08/304,108 patent/US5500425A/en not_active Expired - Fee Related
- 1994-10-23 IL IL11136594A patent/IL111365A/xx not_active IP Right Cessation
- 1994-10-24 IS IS4226A patent/IS1904B/is unknown
- 1994-10-24 ZA ZA948353A patent/ZA948353B/xx unknown
- 1994-10-25 MY MYPI94002832A patent/MY111616A/en unknown
- 1994-10-26 UA UA96041644A patent/UA44717C2/uk unknown
- 1994-10-26 TW TW083109886A patent/TW399049B/zh not_active IP Right Cessation
- 1994-10-26 CA CA002173257A patent/CA2173257C/en not_active Expired - Fee Related
- 1994-10-26 RU RU96110205A patent/RU2142951C1/ru not_active IP Right Cessation
- 1994-10-26 DK DK94931725T patent/DK0725779T3/da active
- 1994-10-26 PT PT94931725T patent/PT725779E/pt unknown
- 1994-10-26 SI SI9430386T patent/SI0725779T1/xx unknown
- 1994-10-26 SG SG1996002730A patent/SG52320A1/en unknown
- 1994-10-26 SK SK436-96A patent/SK280527B6/sk unknown
- 1994-10-26 JP JP07512559A patent/JP3089276B2/ja not_active Expired - Fee Related
- 1994-10-26 WO PCT/SE1994/001010 patent/WO1995011891A1/en active IP Right Grant
- 1994-10-26 AU AU80697/94A patent/AU687115B2/en not_active Ceased
- 1994-10-26 EE EE9600049A patent/EE03253B1/xx not_active IP Right Cessation
- 1994-10-26 EP EP94931725A patent/EP0725779B1/en not_active Expired - Lifetime
- 1994-10-26 ES ES94931725T patent/ES2160640T3/es not_active Expired - Lifetime
- 1994-10-26 PL PL94314086A patent/PL178840B1/pl not_active IP Right Cessation
- 1994-10-26 BR BR9407910A patent/BR9407910A/pt not_active Application Discontinuation
- 1994-10-26 HU HU9601103A patent/HUT75060A/hu unknown
- 1994-10-26 AT AT94931725T patent/ATE203019T1/de not_active IP Right Cessation
- 1994-10-26 CZ CZ961114A patent/CZ284371B6/cs not_active IP Right Cessation
- 1994-10-26 DE DE69427704T patent/DE69427704T2/de not_active Expired - Fee Related
- 1994-10-26 CN CN94194312A patent/CN1062269C/zh not_active Expired - Fee Related
- 1994-10-26 NZ NZ275176A patent/NZ275176A/en unknown
- 1994-10-28 HR HR940890A patent/HRP940890B1/xx not_active IP Right Cessation
- 1994-10-28 YU YU62294A patent/YU49048B/sh unknown
- 1994-11-16 SA SA94150317A patent/SA94150317B1/ar unknown
-
1995
- 1995-05-26 US US08/451,983 patent/US5650524A/en not_active Expired - Fee Related
- 1995-05-30 US US08/453,494 patent/US5646309A/en not_active Expired - Fee Related
- 1995-05-30 US US08/453,648 patent/US5656658A/en not_active Expired - Fee Related
- 1995-05-30 US US08/455,113 patent/US5656657A/en not_active Expired - Fee Related
- 1995-05-30 US US08/453,630 patent/US5639784A/en not_active Expired - Fee Related
- 1995-05-30 US US08/452,982 patent/US5641807A/en not_active Expired - Fee Related
- 1995-05-30 US US08/453,225 patent/US5639772A/en not_active Expired - Fee Related
-
1996
- 1996-04-26 NO NO19961687A patent/NO314146B1/no unknown
- 1996-04-26 FI FI961809A patent/FI961809A/fi not_active IP Right Cessation
-
1998
- 1998-03-10 HK HK98101998A patent/HK1002898A1/xx not_active IP Right Cessation
-
2001
- 2001-09-26 LV LVP-01-138A patent/LV12811B/xx unknown
- 2001-10-05 GR GR20010401676T patent/GR3036816T3/el not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GR3036816T3 (en) | Novel (r)-5-carbamoyl-8-fluoro-3-n,n-disubstituted-amino-3,4-dihydro-2h-1-benzopyranes | |
IL104006A (en) | Azaheterocyclylmethyl-chromans their preparation and pharmaceutical compositions containing them | |
BG104356A (en) | Compounds based on azabenzimidazole for the modulation of serin/treonin protein kinase function | |
CA2012876A1 (en) | Use of 5-methyltetrahydrofolic acid and 5-formyltetrahydrofolic acid in the treatment of organic mental disturbances | |
AU2626492A (en) | 2- aminomethyl-chromans | |
BG100830A (en) | Naphthylamides as central nervous system agents | |
TW225532B (fi) | ||
UA27749C2 (uk) | Заміщені циклопропіламіно-1,3,5-триазини, їх оптичні ізомери, рацемічні суміші чи їх солі приєднання нетоксичних фармацевтично прийнятних кислот, що мають фармакологічну активність, спосіб їх одержання (варіанти) та фармацевтична композиція на їх основі | |
MY120976A (en) | 2-amino-6-(2-substituted-4-phenoxy)- substituted- pyridines | |
IL114599A0 (en) | Substituted pyrimidine compounds their preparation and pharmaceutical compositions containing them | |
YU211087A (en) | Process for obtaining new n-substituted benzimidazolic derivatives | |
MX9403088A (es) | Composiciones farmaceuticas que contienen deriva- dos de indol y metodos de uso. | |
MX9604762A (es) | Nuevas sulfonamidas y procedimiento para su preparacion. | |
MY107354A (en) | Substituted cyclohexenes as central nervous system agents | |
IL109076A0 (en) | Imidazolo-quinoxalinones, their preparation and pharmaceutical compositions containing them | |
UA37211C2 (uk) | Похідні 1,4-дигідропіридину у формі рацемату або енантіомерів, 2-хлор-3-ціанобензальдегід як проміжний продукт для їх одержання та фармацевтична композиція, що має антагоністичну активність по відношенню до катіонів кальцію | |
IL115004A (en) | Pharmaceutical compositions containing substituted 6-amino-4H-pyrans certain novel such compounds and their preparation | |
AU5768298A (en) | Use of benzoylalkyl-1,2,3,6-tetrahydropyridins | |
CA2154485A1 (en) | Pharmaceutical composition containing 5-morpholinomethyl-3-(4-chlorobenzylideneamine)-2-oxazolidinone and its use for the treatment of cns disorders | |
MX9703610A (es) | Nuevas (5,6)-heteroaril condensado-pirimidin-4-onas 2,3 disustituidas. | |
MX9709684A (es) | Uso de derivados de vitamina d4 para tratamiento de trastornos de la piel. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A1OB | Publication of a patent application | ||
AIPI | Request for the grant of a patent on the basis of a substantive examination of a patent application | ||
PNAN | Change of the applicant name, address/residence |
Owner name: ASTRA AKTIEBOLAG, SE |
|
B1PR | Patent granted | ||
ODRP | Renewal fee for the maintenance of a patent |
Payment date: 20051013 Year of fee payment: 12 |
|
PBON | Lapse due to non-payment of renewal fee |
Effective date: 20061029 |